Bihari C, Rastogi A, Saxena P et al. Parvovirus b19 associated
hepatitis. Hepat Res Treat 2013;2013:472027.
Krygier DS, Steinbrecher UP, Petric M et al. Parvovirus
B19 induced hepatic failure in an adult requiring liver
transplantation. World J Gastroenterol 2009; 15(32): 4067–9.
Kerr JR, Boyd N. Autoantibodies following parvovirus B19
infection. J Infect 1996;32:41–7.
Parvovirus-induced autoimmune hepatitis: First case in the literature
Parvovirus B19 infection is usually self-limiting in immunocompetent individuals. Twenty-five percent of infected individuals are
completely asymptomatic during infection, with 50% of them presenting flu-like symptoms and the remaining patients presenting
erythema infectiosum, arthralgia, or arthritis. More rarely, transient aplastic crisis is seen in individuals with chronic haemolytic
disorders. Chronic pure red cell aplasia and aplastic anaemia may also be observed in immunocompromised patients. There is
sufficient evidence in the literature suggesting that B19 infections can also cause a spectrum of liver diseases, ranging from elevated
transaminase levels to acute hepatitis, fulminant liver failure, and even chronic hepatitis. This case report discusses a patient with
acute parvovirus infection and newly diagnosed autoimmune hepatitis (AIH) and the role of this viral infection in the disease.
Bihari C, Rastogi A, Saxena P et al. Parvovirus b19 associated
hepatitis. Hepat Res Treat 2013;2013:472027.
Krygier DS, Steinbrecher UP, Petric M et al. Parvovirus
B19 induced hepatic failure in an adult requiring liver
transplantation. World J Gastroenterol 2009; 15(32): 4067–9.
Kerr JR, Boyd N. Autoantibodies following parvovirus B19
infection. J Infect 1996;32:41–7.
Yavuz, A., Toksoz Yıldırım, A. N., Yılmaz Enc, F., Tuncer, I. (2022). Parvovirus-induced autoimmune hepatitis: First case in the literature. Marmara Medical Journal, 35(3), 376-378. https://doi.org/10.5472/marumj.1195421
AMA
Yavuz A, Toksoz Yıldırım AN, Yılmaz Enc F, Tuncer I. Parvovirus-induced autoimmune hepatitis: First case in the literature. Marmara Med J. October 2022;35(3):376-378. doi:10.5472/marumj.1195421
Chicago
Yavuz, Arda, Ayse Nur Toksoz Yıldırım, Feruze Yılmaz Enc, and Ilyas Tuncer. “Parvovirus-Induced Autoimmune Hepatitis: First Case in the Literature”. Marmara Medical Journal 35, no. 3 (October 2022): 376-78. https://doi.org/10.5472/marumj.1195421.
EndNote
Yavuz A, Toksoz Yıldırım AN, Yılmaz Enc F, Tuncer I (October 1, 2022) Parvovirus-induced autoimmune hepatitis: First case in the literature. Marmara Medical Journal 35 3 376–378.
IEEE
A. Yavuz, A. N. Toksoz Yıldırım, F. Yılmaz Enc, and I. Tuncer, “Parvovirus-induced autoimmune hepatitis: First case in the literature”, Marmara Med J, vol. 35, no. 3, pp. 376–378, 2022, doi: 10.5472/marumj.1195421.
ISNAD
Yavuz, Arda et al. “Parvovirus-Induced Autoimmune Hepatitis: First Case in the Literature”. Marmara Medical Journal 35/3 (October 2022), 376-378. https://doi.org/10.5472/marumj.1195421.
JAMA
Yavuz A, Toksoz Yıldırım AN, Yılmaz Enc F, Tuncer I. Parvovirus-induced autoimmune hepatitis: First case in the literature. Marmara Med J. 2022;35:376–378.
MLA
Yavuz, Arda et al. “Parvovirus-Induced Autoimmune Hepatitis: First Case in the Literature”. Marmara Medical Journal, vol. 35, no. 3, 2022, pp. 376-8, doi:10.5472/marumj.1195421.
Vancouver
Yavuz A, Toksoz Yıldırım AN, Yılmaz Enc F, Tuncer I. Parvovirus-induced autoimmune hepatitis: First case in the literature. Marmara Med J. 2022;35(3):376-8.
